Richard Bryan Riggsbee, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 30,000 shares at $19.09 ($573K) on 2023-12-01, disclosed to the SEC on 2023-12-05.
Scheduled sale ($573k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MYGN | SELL | 2023-01-23 | $188K | — | Filing → |
| MYGN | SELL | 2023-01-19 | $12K | — | Filing → |
| MYGN | SELL | 2022-12-28 | $303K | — | Filing → |